These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38348581)

  • 1. Methods for the estimation of direct and indirect vaccination effects by combining data from individual- and cluster-randomized trials.
    Wang R; Cen M; Huang Y; Qian G; Dean NE; Ellenberg SS; Fleming TR; Lu W; Longini IM
    Stat Med; 2024 Apr; 43(8):1627-1639. PubMed ID: 38348581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing effects of cholera vaccination in the presence of interference.
    Perez-Heydrich C; Hudgens MG; Halloran ME; Clemens JD; Ali M; Emch ME
    Biometrics; 2014 Sep; 70(3):731-44. PubMed ID: 24845800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The design and analysis of cholera vaccine trials: recent lessons from Bangladesh.
    Clemens J; Sack D; Rao M; Chakraborty J; Kay B; Ahmed F; Khan MR; van Loon FP; Svennerholm AM; Holmgren J
    Int J Epidemiol; 1993 Aug; 22(4):724-30. PubMed ID: 8225749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial.
    Ali M; Debes AK; Luquero FJ; Kim DR; Park JY; Digilio L; Manna B; Kanungo S; Dutta S; Sur D; Bhattacharya SK; Sack DA
    PLoS Med; 2016 Sep; 13(9):e1002120. PubMed ID: 27622507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of adding hand-washing and water disinfection promotion to oral cholera vaccination on diarrhoea-associated hospitalization in Dhaka, Bangladesh: evidence from a cluster randomized control trial.
    Najnin N; Leder K; Qadri F; Forbes A; Unicomb L; Winch PJ; Ram PK; Leontsini E; Nizame FA; Arman S; Begum F; Biswas SK; Clemens JD; Ali M; Cravioto A; Luby SP
    Int J Epidemiol; 2017 Dec; 46(6):2056-2066. PubMed ID: 29025064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design.
    Ali M; You YA; Sur D; Kanungo S; Kim DR; Deen J; Lopez AL; Wierzba TF; Bhattacharya SK; Clemens JD
    Vaccine; 2016 Jan; 34(4):479-485. PubMed ID: 26707378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leveraging contact network structure in the design of cluster randomized trials.
    Harling G; Wang R; Onnela JP; De Gruttola V
    Clin Trials; 2017 Feb; 14(1):37-47. PubMed ID: 27798376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India.
    Ali M; Sur D; You YA; Kanungo S; Sah B; Manna B; Puri M; Wierzba TF; Donner A; Nair GB; Bhattacharya SK; Dhingra MS; Deen JL; Lopez AL; Clemens J
    Clin Infect Dis; 2013 Apr; 56(8):1123-31. PubMed ID: 23362293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.
    Ali M; Qadri F; Kim DR; Islam T; Im J; Ahmmed F; Chon Y; Islam Khan A; Zaman K; Marks F; Clemens JD
    Int J Epidemiol; 2019 Aug; 48(4):1252-1261. PubMed ID: 30968110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socioeconomic drivers of vaccine uptake: An analysis of the data of a geographically defined cluster randomized cholera vaccine trial in Bangladesh.
    Saha A; Hayen A; Ali M; Rosewell A; MacIntyre CR; Clemens JD; Qadri F
    Vaccine; 2018 Jul; 36(31):4742-4749. PubMed ID: 29752024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial.
    Fong Y; Halloran ME; Park JK; Marks F; Clemens JD; Chao DL
    BMC Infect Dis; 2018 Feb; 18(1):84. PubMed ID: 29463233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing different measures of population-level vaccine protection using a case-control study.
    Ali M; You YA; Kanungo S; Manna B; Deen JL; Lopez AL; Wierzba TF; Bhattacharya SK; Sur D; Clemens JD
    Vaccine; 2015 Nov; 33(48):6878-83. PubMed ID: 26364121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.
    Qadri F; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Begum YA; Bhuiyan TR; Chowdhury MI; Uddin MJ; Khan JAM; Chowdhury AI; Rahman A; Siddique SA; Asaduzzaman M; Akter A; Khan A; Ae You Y; Siddik AU; Saha NC; Kabir A; Riaz BK; Biswas SK; Begum F; Unicomb L; Luby SP; Cravioto A; Clemens JD
    Lancet; 2015 Oct; 386(10001):1362-1371. PubMed ID: 26164097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.
    Khan IA; Saha A; Chowdhury F; Khan AI; Uddin MJ; Begum YA; Riaz BK; Islam S; Ali M; Luby SP; Clemens JD; Cravioto A; Qadri F
    Vaccine; 2013 Dec; 31(51):6058-64. PubMed ID: 24161413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats.
    Longini IM; Yang Y; Fleming TR; Muñoz-Fontela C; Wang R; Ellenberg SS; Qian G; Halloran ME; Nason M; Gruttola V; Mulangu S; Huang Y; Donnelly CA; Henao Restrepo AM
    Clin Trials; 2022 Dec; 19(6):647-654. PubMed ID: 35866633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines.
    Durham LK; Longini IM; Halloran ME; Clemens JD; Nizam A; Rao M
    Am J Epidemiol; 1998 May; 147(10):948-59. PubMed ID: 9596473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral vaccines for preventing cholera.
    Sinclair D; Abba K; Zaman K; Qadri F; Graves PM
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD008603. PubMed ID: 21412922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interplay between WASH practices and vaccination with oral cholera vaccines in protecting against cholera in urban Bangladesh: Reanalysis of a cluster-randomized trial.
    Chowdhury F; Aziz AB; Ahmmed F; Ahmed T; Kang SS; Im J; Park J; Tadesse BT; Islam MT; Kim DR; Hoque M; Pak G; Khanam F; McMillan NAJ; Liu X; Zaman K; Khan AI; Kim JH; Marks F; Qadri F; Clemens JD
    Vaccine; 2023 Mar; 41(14):2368-2375. PubMed ID: 36898931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.